Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Jan;88(1045):20140630.
doi: 10.1259/bjr.20140630.

Pre-radiotherapy identification of individual genomic profile to avoid, by resort to customized radiosensitizers, the risk of radioresistance development in patients with localized prostate cancer

C Alberti  1
Affiliations
Comment

Pre-radiotherapy identification of individual genomic profile to avoid, by resort to customized radiosensitizers, the risk of radioresistance development in patients with localized prostate cancer

C Alberti. Br J Radiol. 2015 Jan.
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Bristow RG, Berlin A, Dal Pra A. An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy. Br J Radiol 2014; 88: 20130753. doi:10.1259/bjr.20130753 - DOI - PMC - PubMed
    1. Kuger S, Corek E, Polat B, Kammerer U, Flentje M, Djuzenova CS. Novel PI3K and mTOR inhibitor NVP-BEZ235 radiosensitizes breast cancer cell lines under normoxic and hypoxic conditions. Breast Cancer (Auckl) 2014; 8: 39–49. doi: 10.4137/BCBCR.S13693 - DOI - PMC - PubMed
    1. Zhang J. Poly (ADP-ribose) polymerase inhibitor: an evolving paradigm in the treatment of prostate cancer. Asian J Androl 2014; 16: 401–6. doi: 10.4103/1008-682X.123684 - DOI - PMC - PubMed
    1. Trautmann F, Cojoc M, Kurth I, Melin N, Bouchez LC, Dubrovska A, et al. . CXCR4 as biomarker for radioresistant cancer stem cells. Int J Radiat Biol 2014; 90: 687–99. doi: 10.3109/09553002.2014.906766 - DOI - PubMed
    1. Schoenfeld JD, Margalit DN, Kasperzyk JL, Shui IM, Rider JR, Epstein MM, et al. . A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer. Clin Cancer Res 2013; 19: 1612–19. doi: 10.1158/1078-0432.CCR-12-2718 - DOI - PMC - PubMed